Men with advanced breast cancer (BC): Initial phase (Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor Meeting Abstract
| Authors: | Elias, A.; Gucalp, A.; Bardia, A.; Resaul, A.; Eisner, J.; Baskin-Bey, E.; Traina, T. A. |
| Abstract Title: | Men with advanced breast cancer (BC): Initial phase (Ph) 2 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402090 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-P5-23-04 |
| Notes: | Meeting Abstract: P5-23-04 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
